BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1402@pharmaconomics
DTSTAMP:20260707T030557Z
DTSTART;VALUE=DATE:20260521
DTEND;VALUE=DATE:20260522
SUMMARY:HCM Approval — fruquintinib
DESCRIPTION:A final FDA approval decision on fruquintinib for renal cell carcinoma is expected May 21\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1648257/000164825726000033/hcm-20260521xex99d1.htm\n\nTrack it: https://pharmaconomics.com/e/1402
URL:https://pharmaconomics.com/e/1402
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:HCM catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR